| NewBio Therapeutics, Inc. is an innovative bio-tech company located in the Zhangjiang Pharma Valley (Pudong, Shanghai). The company was founded on Feb. 18, 2011, with registered capital of 20 million yuan. Our R&D is focused on monoclonal antibody and antibody-drug conjugate (ADC) as anti-cancer therapeutics. All pipeline drug candidates are proprietary. Two programs are in phase I clinical trials, and five more programs are in either preclinical study or early discovery stages. NewBio has collaborat… |
 |
 |
|
|
